# UCB Pharma (Belgium)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/ucb-pharma-belgium/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 47.5 |
| Citations | 263,453 |
| City | Brussels |
| Country | BE |
| Description | UCB Pharma (Belgium) is a research organisation in Brussels, BE. OpenAlex records 3,889 works and 263,453 citations for it. 1,063 researchers list it as their most recent affiliation. |
| Homepage | http://www.ucb.com/ |
| OpenAlex ID | https://openalex.org/I85722119 |
| Region | Brussels Capital |
| Researchers | 1,063 |
| ROR ID | https://ror.org/01n029866 |
| Type | company |
| Works | 3,889 |

## University papers

- [An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest](https://scholariq.org/papers/an-automated-labeling-system-for-subdividing-the-human-cerebral-cortex-on-mri/)
- [Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease](https://scholariq.org/papers/secreted-amyloid-protein-similar-to-that-in-the-senile-plaques-of-alzheimer-s/)
- [Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and \[18F\]fluorodeoxyglucose (FDG)](https://scholariq.org/papers/metabolic-hyperfrontality-and-psychopathology-in-the-ketamine-model-of-psychosis/)
- [Changes in cortical grey matter density associated with long-standing retinal visual field defects](https://scholariq.org/papers/changes-in-cortical-grey-matter-density-associated-with-long-standing-retinal/)

## University top topics

Showing 8 of 25.

- [Epilepsy research and treatment](https://scholariq.org/topics/epilepsy-research-and-treatment/)
- [Pharmacological Effects and Toxicity Studies](https://scholariq.org/topics/pharmacological-effects-and-toxicity-studies/)
- [Neuroscience and Neuropharmacology Research](https://scholariq.org/topics/neuroscience-and-neuropharmacology-research/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Receptor Mechanisms and Signaling](https://scholariq.org/topics/receptor-mechanisms-and-signaling/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.